Joby to Pay $125M for Blade's Helicopter Ride-Share Unit

Key Concepts

• EVTOL (Electric Vertical Take-Off and Landing) Aircraft: Aircraft that can take off and land vertically using electric power.
• Regulatory Support: Government backing and favorable regulations for the EVTOL industry.
• Commercialization: The process of bringing EVTOL technology to market for widespread use.
• Accretive Deal: A deal that benefits both parties involved.
• Type Inspection Authorization (TIA): FAA authorization for Joby to begin manufacturing aircraft intended for certification flight testing.
• Flight Testing: Testing the aircraft in flight to ensure safety and performance.
• M&A (Mergers and Acquisitions): The process of companies consolidating or acquiring other companies.

Rationale for the Blade Acquisition

• Unprecedented Regulatory Support: The White House, DOT, and FAA are actively supporting the EVTOL industry, creating a favorable environment for commercialization. Regulators worldwide are also enthusiastic.
• Joby's Progress: Joby is making significant progress in certification and manufacturing, doubling its manufacturing rate.
• Blade's Network: Blade has established a strong network of takeoff and landing locations, exclusive lounges, and a focus on customer service.
• Strategic Partnership: The acquisition of Blade's passenger business and partnership on the medical business is a strategic move for Joby.

Accelerating EVTOL Market Entry

• Executive Order Catalyst: The recent executive order from the administration is expected to accelerate the timeline for EVTOL market entry.
• Continued Helicopter Rideshare Operations: Joby plans to not only operate Blade's existing helicopter rideshare business but also grow it significantly.
• Quiet Aircraft and New Locations: Joby's quiet aircraft technology will enable operations from a greater number of takeoff and landing locations.
• Real Estate Developer Interest: Real estate developers are eager to incorporate takeoff and landing locations into their developments.

Deal Structure and Benefits

• Accretive for Both Sides: The deal is structured to benefit both Joby and Blade.
• Joby's Gains: Joby gains Blade's established passenger business.
• Blade's Gains: Blade's medical business gains access to Joby's EVTOL and hydrogen-electric aircraft.
• Focus on Medical Growth: The deal allows Blade's medical business to focus on growth with dedicated resources.
• Financial Details: Joby is committing $125 million in stock or cash to the deal.

Regulatory Process and Flight Testing

• Type Inspection Authorization (TIA): Joby has received TIA and is manufacturing aircraft for flight testing.
• FAA Involvement: FAA representatives are present at the factory, inspecting parts and systems.
• Flight Testing with FAA Pilots: Flight testing with FAA pilots is scheduled to begin early next year.
• Commercialization Journey: Joby is nearing the end of a long journey and is preparing for commercialization.

Future M&A Opportunities

• Global Opportunities: Joby sees significant M&A opportunities in other geographies, particularly in Europe.
• Demand and Congestion: High demand and congestion in cities worldwide create a need for EVTOL solutions.

Investor Reaction and Deal Value

• Positive Investor Signal: The increase in Joby's stock price after the deal announcement indicates that investors view the deal favorably.
• Win-Win for Shareholders: The deal is considered a win-win for both Blade and Joby shareholders.
• Acceleration of Rollout: The acquisition is expected to significantly accelerate Joby's rollout in the US and globally.
• Operational Expertise and Infrastructure: Joby gains operational expertise, infrastructure, and customer service capabilities from Blade.

Notable Quotes

• "This is going to be a massive accelerant for for Joby and for our rollout both here in the US and around the world."
• "...we can't wait to scale this this service and really bring the magic of flight to people's daily lives."

Synthesis/Conclusion

The acquisition of Blade's passenger business by Joby Aviation is a strategic move driven by favorable regulatory conditions, Joby's progress in certification and manufacturing, and Blade's established network. The deal is structured to be accretive for both companies, accelerating Joby's commercialization efforts and providing Blade's medical business with access to advanced aircraft technology. Positive investor reaction suggests confidence in the deal's potential to drive growth and expand Joby's global reach. The focus now shifts to flight testing with FAA involvement and preparing for the commercial launch of EVTOL services.